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Background: Previous studies have shown that increased excitability of capsaicin-sensitive DRG neurons and thermal
hyperalgesia in rats with short-term (2–4 weeks) streptozotocin-induced diabetes is mediated by upregulation of T-type
Ca2+ current. In longer–term diabetes (after the 8th week) thermal hyperalgesia is changed to hypoalgesia that is
accompanied by downregulation of T-type current in capsaicin-sensitive small-sized nociceptors. At the same
time pain symptoms of diabetic neuropathy other than thermal persist in STZ-diabetic animals and patients
during progression of diabetes into later stages suggesting that other types of DRG neurons may be sensitized
and contribute to pain. In this study, we examined functional expression of T-type Ca2+ channels in capsaicin-
insensitive DRG neurons and excitability of these neurons in longer-term diabetic rats and in thermally hypoalgesic
diabetic rats.
Results: Here we have demonstrated that in STZ-diabetes T-type current was upregulated in capsaicin-insensitive low-
pH-sensitive small-sized nociceptive DRG neurons of longer-term diabetic rats and thermally hypoalgesic diabetic rats.
This upregulation was not accompanied by significant changes in biophysical properties of T-type channels suggesting
that a density of functionally active channels was increased. Sensitivity of T-type current to amiloride (1 mM) and low
concentration of Ni2+ (50 μM) implicates prevalence of Cav3.2 subtype of T-type channels in the capsaicin-insensitive
low-pH-sensitive neurons of both naïve and diabetic rats. The upregulation of T-type channels resulted in the increased
neuronal excitability of these nociceptive neurons revealed by a lower threshold for action potential initiation, prominent
afterdepolarizing potentials and burst firing. Sodium current was not significantly changed in these neurons during long-
term diabetes and could not contribute to the diabetes-induced increase of neuronal excitability.
Conclusions: Capsaicin-insensitive low-pH-sensitive type of DRG neurons shows diabetes-induced upregulation of Cav3.2
subtype of T-type channels. This upregulation results in the increased excitability of these neurons and may contribute to
nonthermal nociception at a later-stage diabetes.
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Hyperalgesia and allodynia to mechanical and thermal
stimuli are frequent pain symptoms at an early stage of
peripheral diabetic neuropathy, which involves about
66 % of diabetic patients [1, 2]. These symptoms are
caused by sensitization of sensory transduction pathways
that involves modulation of ligand- and voltage-gated
ion channels [3]. At early stages of STZ-induced diabetes
upregulation of T-type channels in small- and medium-
sized nociceptive DRG neurons was found to increase
their excitability contributing to thermal and mechanical
hyperalgesia [4, 5]. In longer-term diabetes thermal
hyperalgesia is changed to hypoalgesia in case of animal
models of diabetes and in diabetic patients [6, 7] (for re-
view see [8]). It is accompanied by downregulation of
TRPV1 [9] and T-type channels in the capsaicin-
sensitive (caps+) subpopulation of small-sized nocicep-
tors [10, 11] most likely leading to decreased excitability
of these neurons. At the same time manifestations of
pain of different origin, e.g., spontaneous pain, mechan-
ical hyperalgesia, and tactile allodynia may persist [8, 12]
suggesting sensitization of capsaicin-insensitive (caps−)
mechanical and/or chemical nociceptors. In particular,
inflammation and acidosis developing under diabetic
conditions [13–15] may cause sensitization of capsaicin-
insensitive low pH-sensitive (caps−lpH+) DRG neurons
through the pathway involving ASICs [16, 17]. Modula-
tion of Ca2+ and Na+ voltage-gated ion channels leading
to increased excitability of nociceptive neurons is a fre-
quent hallmark of sensitization in diabetes and painful
neuropathies [4, 9, 10, 18, 19]. Thus, the objective of this
study was to find out whether nociceptive caps−lpH+
DRG neurons show upregulation of Ca2+ and Na+
voltage-gated channels and increased excitability in
longer-term diabetes when thermal sensory modality is
downregulated. Here, we report on a specific caps−lpH+
type of DRG neurons that exhibits increased excitability
in the longer-term STZ-diabetic rats and is likely in-
volved in nonthermal nociception at the later-stage
diabetes.
Results
Isolation of capsaicin-insensitive low-pH-sensitive nociceptive
DRG neurons
The scope of search for the caps−lpH+ neurons was lim-
ited to a population of small-sized DRG neurons
(<25 pF) that provided enrichment in C-fibre nocicep-
tors [20], and to L4-L6 ganglia where neurons innervat-
ing hind paws are localized. Isolation of the caps−lpH+
nociceptive DRG neurons was based on classification of
DRG neuronal types [21]. First, separate types of neurons
were identified in the aforementioned subpopulation of
DRG neurons based on size and set of K+ current charac-
teristics [21] (activation threshold, presence of A-typefast-inactivating component, K+ current inactivation time
constant (τinh)). Next, these types were tested for expres-
sion of capsaicin-activated and transient low-pH-activated
currents, and for fast-inactivating T-type current involved
in abnormalities of thermal and mechanical sensitivity
under diabetic conditions [4, 5]. The caps−lpH+ DRG neu-
rons (Fig 1a, b) expressing fast-inactivating T-type current
(Fig 1c) selected in this way have appeared to be the mem-
bers of one type with a distinct set of physical and elec-
trical parameters. Neurons of this type had a very small
size (their capacitance was in a range 10–21 pF with a
mean value of 15.4 ± 0.7 pF, n = 19, four rats). They also
expressed K+ current with a specific “current signa-
ture”: (i) an activation threshold of −20 mV, (ii) no ob-
vious A-type component, and (iii) slow inactivation
(τinact fell within a range of 53–419 ms with a mean
value of 209 ± 31 ms, n = 19, four rats; Fig 1d).
In order to verify that the neuronal size, presence of
fast-inactivating T-type current (Fig 1c) and K+ current
characteristics mentioned above (Fig 1d) represent suffi-
cient criterion for identifying the caps−lpH+ DRG neu-
rons, cells (n = 8, three rats) having these characteristics
were selected among small-sized DRG neurons and chal-
lenged by applications of capsaicin and low pH. All of
them were found to be capsaicin-insensitive (TRPV1
lacking) and low-pH sensitive implying that size and
specific current profile were sufficient to identify the
caps−lpH+ DRG neurons. In the following electrophysio-
logical experiments the caps−lpH+ nociceptive DRG neu-
rons were routinely selected based on their size,
presence of fast-inactivating T-type current and K+
current characteristics (Fig 1c, d). In some experiments
the caps−lpH+ neurons were additionally challenged with
capsaicin in order to check their TRPV1 lacking
phenotype.
The transient low-pH-induced current in the caps−lpH+
neurons (Fig 1b) was sensitive to amiloride (data not
shown), which is a hallmark of ASIC channels [22, 23].
Characteristic rise time of low-pH-activated current (time
from a first deflection to 90 % of peak amplitude) at pH
jump from 7.4 to 5.0 was 522 ± 67 ms (n = 8, three rats)
and its inactivation time constant was 847 ± 72 ms (n = 8,
three rats). This relatively slow inactivation of low-pH-
induced current in the caps−lpH+ neurons suggests that it
might be potentially mediated by Ca2+ permeable ASIC1a
homomultimers [24].
Next, we tested whether the caps−lpH+ neurons were
nociceptive. It has been previously shown that AP over-
shoot, AP duration at the base (APb), and afterhyperpo-
larization (AHP) duration at 80 % recovery (AHP80)
have the largest values for nociceptive neurons among
the whole population of DRG neurons [25]. AP over-
shoot, APb and AHP80 of APs induced in the caps−lpH+
neurons in response to a short (1 ms) threshold current
Fig. 1 (See legend on next page.)
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Fig. 1 Electrophysiological and pharmacological properties of the caps−lpH+ small-sized DRG neurons studied for diabetes-induced changes in T-type
current. a A representative trace showing absence of capsaicin-induced current in the caps−lpH+ neurons. b A representative trace demonstrating
substantial low-pH-induced current in the caps−lpH+ neurons. c Representative traces of Ba2+ currents demonstrating expression of T-type channels in
the caps−lpH+ neurons. The currents were evoked by voltage depolarizing steps from a holding potential of −100 mV to −80 through −10 mV in
10 mV increments. d Representative traces of total currents recorded in the caps−lpH+ neurons that included Na+, Ca2+ and K+ components. The
currents were evoked by voltage steps from a holding potential of −100 to −60 through 40 mV in 20 mV increments. e At the top, a representative
trace of AP evoked by a threshold 1 millisecond-long current pulse shown at the bottom. APb is an action potential duration at the base. AHP80 is the
time required for the AHP to decay to 80 % of its peak value. f An example demonstrating that the caps−lpH+ neurons are IB4-negative. A fluorescent
image of DRG neurons stained for IB4 is shown in the left rectangle. Two IB4-positive small DRG neurons are clearly visible in the top right corner of the
image. White box in a bottom left corner of the image indicates an area where IB4-negative caps−lpH+ neuron is located. Fluorescent and transmitted light
images of the boxed caps−lpH+ neuron are presented in the top and bottom right squares, respectively. The IB4-negative caps−lpH+ neuron is outlined
with a white dashed circle on fluorescent images and a black dashed circle on transmitted light image. No IB4 fluorescence is visible on the plasma
membrane of this caps−lpH+ neuron. A scale bar is 15 μm. This neuron had a K+ “current signature” specific for the caps−lpH+ DRG neurons
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correspondently (n = 7, three rats; Fig 1e). These values
were close (for AP duration) or substantially larger (for
AP overshoot, AHP80) than respective values for C-fibre
nociceptive neurons (AP overshoot ~ 22 mV, APb ~ 6 ms
and AHP80 ~ 22 ms [25]) confirming that the caps−lpH+
neurons are likely nociceptive.
For additional characterization the caps−lpH+ neurons
were checked for binding of isolectin B4 (IB4) widely
used to discriminate GDNF-dependent nonpeptidergic
(IB4 positive) from NGF-dependent peptidergic (IB4
negative) DRG neurons [26, 27], and appeared to be IB4
negative (Fig 1 f, 7 out of 7 neurons tested, three rats).
Thus, our results allow to classify the caps−lpH+ neurons
studied in this work as peptidergic C-fiber nociceptors
lacking TRPV1 receptors and expressing ASIC channels.
Increased functional expression of T-type channels in the
caps−lpH+ neurons of longer-term diabetic rats
The caps−lpH+ DRG neurons are likely to be peptidergic
C-fiber nociceptors lacking TRPV1 receptors and ex-
pressing both ASIC channels and fast-inactivating T-
type channels. It suggests their possible involvement in
pain symptoms (other than thermal hyperalgesia) of
longer-term (12 weeks) diabetic neuropathy [7, 8, 12].Table 1 Blood glucose level and body weight of experimental rats




Body weight, g 325 + 25 212 + 20d 323 + 12
Blood glucose level, mM 4.5 + 0.3 27 + 2f 4.4 + 0.2
n 4 4 3
aAnimals (8 months old) were used to measure T-type current and excitability param
bAnimals (8 months old) were used to measure Na+ current
cAnimals were used to measure T-type current
dANOVA one way test, p < 0.01
eThere was no significant difference between the group of diabetic hypoalgesic or
fStudent’s t-test: p < 0.001 for each control and corresponding diabetic group
gStudent’s t-test with α level adjusted with Bonferroni’s procedure: p < 0.005 when d
control groupSince T-type current upregulation in small nociceptive
DRG neurons is involved in diabetes-induced mechanical
hyperalgesia [4], we checked whether such upregulation oc-
curs in the caps−lpH+ DRG neurons of longer-term (9–13
weeks) diabetic rats, for which multiple pain symptoms in-
cluding mechanical hyperalgesia have been demonstrated
[7, 8, 12]. Blood glucose level and body weight of diabetic
animals at this stage of diabetes were significantly different
from the control group (Table 1). Mean capacitance of
these neurons (16.6 ± 0.4 pF, n = 17, four rats) was not
significantly different compared to control (15.4 ± 0.7 pF,
n = 19, four rats; P > 0.12) indicating that the caps−lpH+
neurons preserved their size in longer-term diabetes.
Changes in Ca2+ current density were tracked separately
for transient and persistent components (Fig 2a-c, see sec-
tion Analysis in Methods for the definition). In a range of
voltage steps from −100 mV to −80 through −40 mV both
components are predominantly represented by T-type
current. Starting from a voltage step to −30 mV N-type
current (having the inactivation kinetics intermediate be-
tween T-type and L-type current) substantially contributes
to the transient and persistent components of Ba2+ current
[28]. L-type current (having the slowest inactivation kinet-
ics [28]) did also contribute to the persistent component
at voltage steps from −30 to 0 mV (data not shown).Na-current measurementsb 2-3 months old ratsc
Diabetic 9-13
weeks
Control Diabetic 6-7 weeks
Hypoalgesic Hyperalgesic
213 + 14d 153 + 4 128 + 11e 125 + 8e
28 + 2f 4.3 + 0.3 27 + 2g 26 + 2g
3 3 3 3
eters
hyperalgesic and control rats (p > 0.08, ANOVA one way test)
iabetic hypoalgesic and hyperalgesic groups were compared with the same
Fig. 2 (See legend on next page.)
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Fig. 2 T-type channels are specifically upregulated in the caps−lpH+ neurons of longer-term diabetic rats without changes in their biophysical
properties. a Representative traces of Ba2+ current recorded in the caps−lpH+ neurons of control and diabetic rats. Currents were evoked by a
depolarization step from a holding potential of −100 to −50 mV. b Diabetes-induced upregulation of T-type channels is revealed at the plot of
the transient current density, TCD, versus a depolarizing voltage step in the activation protocol. An insert demonstrates TCD amplitude for each
tested neuron and their mean values (boxes) with standard errors (upper whiskers) in the control (c) and diabetic (d) neurons at a depolarization
step to −50 mV. c HVA currents were not changed under diabetic conditions as revealed at the plot of persistent Ba2+ current versus depolarizing
step in the activation protocol. The averaged value of Ba2+ current during last 10 ms of depolarization step was taken as a persistent current
amplitude. Current densities are not significantly different between diabetes and control in a range of voltage steps from −30 to 0 mV where
HVA currents are main contributors to the persistent current (p > 0.05). An insert demonstrates persistent current density amplitude for each
tested neuron and their mean values (boxes) with standard errors (upper whiskers) in the control (c) and diabetic (d) neurons at a depolarization
step to −20 mV. d Biophysical properties of T-type channels of the caps−lpH+ neurons are not changed in longer-term diabetes. Inactivation of
normalized transient current (left curves) calculated for experimental results depicted in E; activation of normalized transient current conductance
(right curves) for the experimental results depicted in B. e Diabetes-induced upregulation of T-type channels is revealed in a voltage-dependent
inactivation protocol for evoking transient Ba2+ currents consisted of depolarization steps to a test potential of −40 mV (250 ms) from a holding
potential ranging from −100 to −40 mV (3.5 s) with 10 mV increments. f Time to peak, TTP, for Ba2+ currents recorded in a protocol used to
estimate the transient current activation. g Inactivation time constant, τ, obtained from a single-exponential fit of the decaying phase of the
currents evoked in the activation protocol. Numbers of cells: 19 cells from 4 rats in control group and 17 cells from 4 rats in diabetic group. Data
are expressed as Mean ± S.E.M. *p < 0.02, **p < 0.001
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transient current density (TCD) in the caps−lpH+ neu-
rons in diabetes compared to control at depolarization
steps from −100 mV to −60 through −40 mV (Fig 2a,b).
For example, TCD at a test step to −60 mV, at which T-
type current solely contributed to Ca2+ current, was 1.7
times higher in diabetic neurons compared to control.
At the same time the persistent current density did not
differ significantly between neurons of diabetic and con-
trol rats in a range of voltage steps from −30 to 0 mV
(Fig 2c) indicating that HVA currents were not changed
under diabetic conditions.
Fitting of steady-state activation of T-type current was
further used to evaluate T-type channel remodeling in the
caps−lpH+ neurons of diabetic animals (see section Ana-
lysis in the Materials for details). This fitting demonstrated
that the maximal conductance of T-type current, Gmax,
was significantly increased in the caps−lpH+ neurons iso-
lated from diabetic rats (0.34 ± 0.03 pA/(pF*mV) versus
0.22 ± 0.03 pA/(pF*mV) in control; P < 0.005), while other
fitting parameters,V50 and k, were not significantly chan-
ged (V50 = −50 ± 0.5 mV, k = 5.5 ± 0.3 mV compared to
V50 = −50 ± 0.4 mV, k = 5.0 ± 0.2 mV for control; P > 0.95
and P > 0.13 for V50 and k, correspondently, Fig 2d). TCDs
in a steady-state inactivation protocol were also signifi-
cantly different between neurons from diabetic and control
rats at low conditional potentials (−100 mV and −90 mV;
Fig 2e) (see section Analysis in the Materials and Methods
for details). Fitting data with a function Imax/(1 + exp((V-
V50)/k)) gave a significantly higher value for Imax in diabetes
(−19.4 ± 1.0 pA/pF) compared to control (−12.4 ± 1.7 pA/
pF; P < 0.005). Other fitted parameters did not signifi-
cantly differ between control and diabetic conditions
(control, V50 = −79.1 ± 0.9 mV, k = 4.5 ± 0.2 mV; dia-
betes,V50 = −81.3 ± 0.9 mV, k = 4.5 ± 0.2; P > 0.2 and P >
0.9 for V50 and k, correspondently, Fig 2d).Kinetic parameters of Ba2+ current measured in a
steady-state activation protocol, time to peak (TTP)
and inactivation time constant (τ), were not signifi-
cantly changed in diabetes compared to control (TTP
from 19.6 ± 1.4 to 18.5 ± 1.5 ms, P > 0.5, and τ from
51.3 ± 4.0 to 41.4 ± 2.6 ms, P > 0.05, at a depolarization
step to −50 mV, Fig 2 f, g).
Thus, functional expression of T-type Ca2+ channels,
which is characterized by Gmax and Imax was increased
in the caps−lpH+ DRG neurons of longer-term diabetic
rats. At the same time the gating parameters of T-type
channels (V50 and k for activation, TTP and τ) were not
changed under diabetic conditions.
Upregulation of T-type current in the caps−lpH+ neurons
of 6-7-weeks STZ-diabetic rats with thermal hypoalgesia
Our current data (see previous section) have demon-
strated upregulation of T-type current in the caps−lpH+
neurons in the longer-term (9–13 weeks) diabetic ani-
mals. Previous results have shown that at an earlier stage
of diabetes (6–7 weeks) T-type current is downregulated
in caps+ DRG neurons of thermally hypoalgesic animals
[10]. It remained unclear whether differential expression
of T-type current in the caps+ [10] and caps−lpH+ (previ-
ous section) neurons was due to different sensory mo-
dalities of these neuronal types, or due to differences in
the age of animals and/or duration of diabetes. To ex-
clude the latter reasons we measured T-type current in
the caps−lpH+ DRG neurons of thermally hypoalgesic
rats of the same age (9–10 weeks old) and at the same
stage of diabetes (6–7 weeks), for which downregulation
of T-type current in the caps+ DRG neurons has been
established. Besides, upregulation of T-type current in
the caps−lpH+ neurons of thermally hypoalgesic rats
would also suggest that hyperexcitability of these neu-
rons may underlie diabetic pain symptoms other than
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tactile allodynia), that are observed at a later (6–13
weeks) stage of diabetes development [7, 8, 12].
Subgroups of hypoalgesic and hyperalgesic rats were
isolated within a group of 6–7 week STZ-diabetic
animals by measuring time of hind paw withdrawal la-
tency, PWL, under thermal stimulation. A diabetic rat
was considered to be hypo- or hyperalgesic if its PWL
was correspondently higher or lower than the 95 % con-
fidence interval for PWL distribution of the control
group, which was 16.6÷19.4 s. Hypoalgesic and hyper-
algesic subgroups had correspondently significantly
higher (28.3 ± 1.4 s, 32 tests from three rats) or lower
(11.8 ± 0.8 s, 19 tests from three rats) averaged PWL
compared to control (18 ± 0.7 sec, 28 tests from three
rats; p < 0.001). Blood glucose level in animals of both
diabetic subgroups was significantly higher than in con-
trol animals, while mean body weights for both sub-
groups were not significantly different from control at
6–7 weeks of diabetes (Table 1). These results are similar
to ones obtained in the previous work [10], in which
downregulation of T-type current was shown in caps+
nociceptive neurons. Representative families of total Ba2+
currents in the caps−lpH+ neurons from control and
hypoalgesic animals are shown in Fig 3a. It has appeared
that the caps−lpH+ neurons showed upregulation of low
voltage-activated Ba2+ current in diabetic hypoalgesic ani-
mals (Fig 3). The averaged current–voltage curves of aFig. 3 Diabetes-induced upregulation of T-type channels in the caps−lpH+
traces of Ba2+ current in the caps−lpH+ neurons isolated from the control (
increase of TCD was observed in the caps−lpH+ neurons of diabetic compa
mediated by T-type channels (n = 8 and n = 7, from three animals each, for
neurons were isolated from diabetic animals after 6 weeks of STZ-induced
holding potential of −100 mV to −80 through 0 mV in 10 mV increments.
their mean values (boxes C - for the control and D - for the diabetes) withtransient component normalized to a cell capacitance are
shown in Fig 3b. An increase in TCD in the caps−lpH+
neurons isolated from hypoalgesic rats was significant and
varied from 2.6-fold at a voltage step to −60 mV to 2.8-
fold at a voltage step to −40 mV (Fig 3b). Observed upreg-
ulation of T-type current in the caps−lpH+ neurons of 6–7
weeks diabetic hypoalgesic rats was opposite to previously
found downregulation of T-type current in the caps+
nociceptors of the same animal group [10]. Thus, this up-
regulation was due to specific sensory modalities of the
caps−lpH+ neurons rather than due to differences in the
age of animals or duration of diabetes. It also suggests in-
volvement of TRPV1-independent signal transduction
pathway in upregulation of T-type current in the caps−lpH+
DRG neurons under diabetic conditions. Upregulation of
T-type current in the caps−lpH+ neurons of thermally
hypoalgesic diabetic rats implies their involvement in non-
thermal nociception.
Upregulation of T-type current underlies increased excit-
ability of the caps−lpH+ neurons in diabetic rats
Next, we studied whether upregulation of T-type current
observed in the caps−lpH+ neurons of longer-term diabetic
rats resulted in increased excitability of these neurons.
Excitability was estimated based on two parameters of
neuronal APs: the action potential threshold (APT) deter-
mined at a threshold current stimulation evoking an AP
(Fig 4a) and the afterhyperpolarization/afterdepolarizationneurons of hypoalgesic subgroup of diabetic rats. a Representative
upper traces), hypoalgesic (lower traces) diabetic rats. b Significant
red to control rats in a range of −60 - -0 mV where Ba2+ current is
control and diabetic groups, respectively; *p < 0.05). The caps−lpH+
diabetes. The currents were evoked by depolarizing steps from a
An insert demonstrates TCD amplitude for each tested neuron and
standard errors (upper whiskers) at a depolarization step to −50 mV
Fig. 4 Excitability of the caps−lpH+ neurons is decreased under T-type channel blockers. T-type channel blockers convert the ADP to AHP and
significantly increase the AP threshold for the caps−lpH+ neurons at concentrations effectively blocking the Cav3.2 isoform of T-type channels. a,b
Action potential parameters used for estimation of changes in excitability of the caps−lpH+ DRG neurons (action potential threshold (APT) and
after-depolarization/-hyperpolarization areas (ADP/AHP)). c An example of an AP burst induced by a threshold stimulation in the caps−lpH+
neuron of longer-term diabetic rat instead of a single AP observed in the neurons of normal rats. d Significant decrease of the Ba2+ TCD in the
caps−lpH+ neurons under T-type channel blockers Ni2+ (50 μM) and amiloride (1 mM). TCD amplitudes at a voltage step from −100 to −50 mV
are presented. Insert: representative traces of Ba2+ current before and after application of 50 μM Ni2+. e A representative example of the AP
parameter changes in the caps−lpH+ neurons of diabetic rats under T-type channel blocker, Ni2+ (50 μM). The ADP converted to AHP and the AP
threshold increased in 50 μM Ni2+ (grey trace) compared to control (black trace). The ADP and AHP areas are cross-hatched. The AP threshold
levels are indicated by dashed lines. f,h The ADP/AHP area reversed from positive to negative values under 50 μM Ni2+ (f) and 1 mM amiloride
(h) reflecting conversion of the ADP to AHP shown on (e). g,i Significant AP threshold increase under 50 μM Ni2+ (g) and 1 mM amiloride (i)
Numbers of cells: Ni2+ inhibition, n = 6 from three rats; amiloride inhibition, n = 6 from three rats. *p < 0.05, **p < 0.01
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estimate an APT and AHP/ADP area are shown in grey on
the Fig 4a,b. An increase in the ADP area as well as a de-
crease in the APT were considered to be indications of in-
creased neuronal excitability since the former may cause
burst firing (Fig 4c, [5]) and the latter should lower sensory
input necessary to induce AP.
First, we evaluated variation of excitability parameters
due to variation in T-type current in the caps−lpH+ neu-
rons. Application of T-type channel blocker, Ni2+
(50 μM), onto a subset of the caps−lpH+ neurons having
large ADP (and presumably expressing large T-typecurrent [5]) converted the ADP to AHP and increased
an AP threshold by 10 mV (Fig 4e-g). The AP threshold
trace under Ni2+ application (grey trace) is shifted to the
left compared to control (black trace) because of the
higher value of injected current needed to reach the
higher level of AP threshold (Fig 4e). Ni2+ application
led to a nearly total block of T-type current. Peak transi-
ent Ba2+ current was inhibited by 93 ± 2 % at a voltage
step to −50 mV (Fig 4d), while total Ba2+ current was
inhibited by 84 ± 2 % at this voltage step. Almost
complete block of T-type current by 50 μM of Ni2+ sug-
gested that the Cav3.2 T-type channels (IC50 = 13 μM
Fig. 5 Direct correlation between the AP parameters characterizing
neuronal excitability and TCD in the caps−lpH+ DRG neurons. AP
parameters were measured at the AP initiation threshold in Tyrode’s
solution. TCD was measured in the same neurons at a voltage step
from −100 to −50 mV when the external Tyrode’s solution was
changed for TEA-Cl, Ba2+-based solution. a Significant correlation
between the ADP/AHP area and TCD. Pearson coefficient Pc = 0.78,
p < 1.2*10−5. Number of cells: n = 28 from eight rats b Significant
correlation between the AP threshold and TCD. Pearson coefficient,
Pc = 0.52, p < 0.0015. Number of cells: n = 36 from eight rats
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250 μM and 216 μM, correspondently [29]) mainly con-
tributed to T-type current in the caps−lpH+ DRG neu-
rons. For a double check of the effect of T-type current
block on excitability parameters we applied the other T-
type channel blocker, amiloride, which is selective for
Cav3.2 T-type channel isoform [30–32] and, to the best
of our knowledge, has no significant inhibitory effect on
voltage-gated sodium channels at 1 mM concentration.
When applied at this concentration, amiloride inhibited
Ba2+ current by 76 ± 7 % at a voltage step to −50 mV
(Fig 4d). Weaker inhibition of T-type current with
amiloride resulted in a lesser decrease of the ADP areaand lower increase of the AP threshold, demonstrating
correlation between the T-type current inhibition and
the excitability parameters (Fig 4h, i). So, the highest de-
crease of the ADP area (by 1704 mV*ms; Fig 4 f ) was
observed when T-type current was maximally inhibited
by Ni2+ (by 93 %; Fig 5a) while the ADP area was de-
creased by 1241 mV*ms; Fig 4h) in case of amiloride ap-
plication when T-type current was inhibited by 76 %
(Fig 4d). Analogous relationship was obtained between
the APT and TCD (Fig 4d, g, i). Ni2+-induced inhib-
ition of T-type current led to an APT increase by
10 mV (from −55.4 ± 0.7 to −45.5 ± 2.0 mV) (Fig 4g),
while amiloride application increased the APT by
7 mV (from −56.3 ± 1.3 to −49.8 ± 2.0 mV) (Fig 4i). A
weaker effect of amiloride compared to Ni2+ correlated
with its weaker inhibition of T-type current (76 ± 7 %
for amiloride compared to 93 ± 2 % for Ni2+ at a volt-
age step to −50 mV , Fig 4d).
Correlation between the ADP/AHP area or the AP
threshold and T-type current density was also directly
established for the caps−lpH+ neurons (Fig 5) by measur-
ing AP parameters and TCD for the same neuron in
Tyrode’s and TEA-Cl, Ba2+-based solutions, respectively.
Fig 6 clearly demonstrates a robust correlation between
TCD and AP parameters characterizing neuronal excit-
ability. Corresponding Pearson correlation coefficient
and level of significance for correlation of the ADP/AHP
area and the AP threshold with the TCD were 0.78, p <
1*E−5 and 0.7, p < 0.002, respectively. Thus, T-type
current in the caps−lpH+ neurons is significantly corre-
lated with the neuronal excitability parameters.
This correlation between the values of T-type current
and excitability parameters assumes increased excitabil-
ity of the caps−lpH+ neurons in diabetes when upregula-
tion of T-type current is observed (Fig 2b). Fig 6a,b
show representative AP traces generated in control and
diabetic neurons at a threshold current stimulation
from −90 mV. More than half of diabetic caps−lpH+
neurons (57 %, n = 28, four rats) revealed a prominent
ADP (Fig 6b) whereas majority of control cells (75 %, n =
20, four rats) displayed an AHP (Fig 6a). Statistically it was
manifested in a significant increase of the ADP/AHP area
(by 467 mV*ms) in diabetes compared to control (Fig 6c).
An increased ADP/AHP area resulted in a burst generat-
ing capability of the diabetic caps−lpH+ neurons. These
neurons showed a burst of two spikes with a second spike
crowning an ADP hump (7 out of 28 tested neurons;
Fig 6d), while no bursts were recorded in the caps−lpH+
neurons of control rats (n = 20, four rats). Application of
T-type channel blocker amiloride eliminated the hump at
a threshold current stimulation (Fig 6e), and abrogated
the second spike generated at a slightly higher
depolarization (Fig 6e) implying that T-type channel up-
regulation results in higher excitability of the caps−lpH+
Fig. 6 Diabetic-induced changes of the AP parameters for the caps−lpH+ neurons reflect increased excitability of these neurons in diabetes. a A
representative AP trace with a slight AHP recorded from the caps−lpH+ neuron of normal rat. b A representative AP trace with a substantial ADP
recorded from the caps−lpH+ neuron of diabetic rat. c The ADP/AHP area is significantly increased in diabetes compared to control indicating an
increase in excitability of the caps−lpH+ neurons including probability of their bursting in diabetic conditions. Numbers of cells: control for
diabetes n = 20 from four rats, diabetes n = 28 from four rats, p < 0.05. d A representative trace of AP bursts generated in 25 % of diabetic
neurons (n = 28 from four rats) at a threshold current stimulation. At the same time no AP bursts were observed in the caps−lpH+ neurons of
control rats (n = 20 from four rats). e Application of amiloride converts ADPs (top left) and bursts (bottom left) observed in the diabetic caps−lpH+
neurons to AHPs (top and bottom right). f Diabetes leads to a statistically significant decrease in the AP threshold. Numbers of cells: control for
diabetes n = 20 from four rats, diabetes n = 28 from four rats, p < 0.05
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ity parameter, the AP threshold, was also significantly
decreased (from −53 ± 0.8 in control to −56 ± 1 mV in
longer-term diabetes; Fig 6 f ) suggesting that weaker
sensory stimuli would be enough to evoke AP in the
caps−lpH+ neurons of diabetic rats.
Thus, the obtained results demonstrate increased ex-
citability of the caps−lpH+ neurons in the longer-term
diabetic rats caused by increased functional expression
of the Cav3.2 T-type channels in these neurons.Sodium voltage-operated currents do not contribute to
increased excitability of the caps−lpH+ DRG neurons in
longer-term diabetes
Diabetes-induced remodeling of sodium channels may
also potentially increase the neuronal excitability [9] and
account for the increased excitability of the caps−lpH+
neurons in the longer-term diabetic rats. To find out
whether sodium current might contribute to the in-
creased excitability of the caps−lpH+ neurons in longer-
term STZ diabetes this current was compared in the
Fig. 7 Total voltage-gated Na+ current is not significantly changed in
the caps−lpH+ neurons of diabetic rats. a A representative example of
Na+ currents obtained using a voltage-dependent activation protocol. b
Steady-state activation curves of Na+ current in the caps−lpH+ neurons
of diabetic and control rats. c Steady-state inactivation curves of Na+
current in the caps−lpH+ neurons of diabetic and control rats. n= 7 from
three rats for diabetic and control groups in B and C. Differences in peak
current densities were insignificant (p> 0.05). These results clearly
demonstrate a lack of Na+ current modulation under diabetic conditions
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Fig. 8 TTX-sensitive and TTX-resistant Na+ currents do not contribute to
neuronal excitability in the caps−lpH+ neurons. a Steady-state activation
of TTX-sensitive, TTX-S, component of Na+ current. Insert: representative
traces of TTX-S Na+ current b A part of a low voltage region from A is
presented in a larger scale demonstrating negligible values of TTX-S
current at depolarization steps in a range of −70 - -50 mV (n= 9 from
three rats). c Steady-state activation curve of TTX-resistant, TTX-R,
component of Na+ current demonstrating its activation threshold
at −35 mV (n = 9 from three rats). Insert: representative traces of
TTX-R Na+ current. Altogether these results demonstrate a lack of
low-threshold TTX-R current and substantially lower density of TTX-
S current compared to T-type current [39] at depolarization steps
up to -40 mV
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diabetes-induced changes in sodium current density
were found in a whole range of tested membrane poten-
tials in protocols for channel activation and inactivation
(Fig 7). In fact, the current density in the diabetic neu-
rons was slightly and insignificantly lower compared to
control in a range of low voltage membrane potentials
(up to −40 mV), at which T-type current contributes to
the neuronal excitability (Fig 7b). No significant changes
in parameters of Boltzmann fitting functions, Gmax, Imax,
k and V50, were found in diabetes versus control for
steady-state activation and inactivation of sodium
current (data not shown).
TTX-resistant sodium channels (TTX-R) along with
TTX-sensitive channels (TTX-S) are widely expressed in
small DRG neurons and are implicated in the molecular
mechanisms of nociception and pain [33–35]. Particu-
larly, TTX-R sodium channels encoded by Nav1.9 play a
similar role to that of T-type channels in lowering the
AP threshold and promoting burst discharges [36–38].
Therefore, we pharmacologically isolated TTX-S and
TTX-R components of sodium current in the caps−lpH+
neurons (Fig 8) in order to check whether both compo-
nents are present in these neurons and whether they
may substantially contribute to neuronal excitability. To
isolate the TTX-R component a subtraction procedure
was applied to current traces recorded in a series of dif-
ferent external solutions (see Materials and Methods).
TTX-R current appeared to be small even at the max-
imum of I-V curve (<12 pA/pF) and had an activation
threshold around −35 mV (Fig 8c), lacking a low
voltage-activated component conducted by Nav1.9 chan-
nels and being represented solely by high voltage-
activated current conducted by Nav1.8 channels. Thus,
it could not affect either the ADP area or the AP thresh-
old in the caps−lpH+ neurons in the −80 - -40 mV range
of depolarization, where the sodium current is repre-
sented by its TTX-S component. This component had a
shallow slope of activation curve (from 0 to about 1.6
pA/pF) in a range of test potentials from −80 to −50 mV
(Fig 8a, b) and a density substantially less than one ofT-type Ca2+ current. T-type current density estimated
at the level of an AP threshold of −53 mV in Tyrode’s
solution was ~6 pA/pF (Fig 2b; assuming IBa:ICa = 1.2
[39])) and, therefore, TTX-S could not determine the
AP threshold. Thus, we have found that voltage-
operated sodium channels could not substantially influ-
ence the values of the ADP area and the APT in the
caps−lpH+ neurons and were not upregulated in the
longer-term diabetic rats. At the same time T-type Ca2+
channels were upregulated and definitely contributed
to increased excitability of the caps−lpH+ neurons in
longer-term diabetes.
Discussion
The main finding of this work is that nociceptive caps−lpH+
DRG neurons exhibit increased excitability in longer-term
diabetes due to upregulation of T-type channels. To the
best of our knowledge, this is the first study, in which up-
regulation of T-type calcium channels has been shown
under conditions of thermal hypoalgesia in a specific type
of nociceptors. This finding supports an idea that remodel-
ing of T-type channels in these functionally specific noci-
ceptive neurons may underlie painful states in longer-term
diabetes.
Specific type of DRG neurons reveals upregulation of T-
type current in longer-term diabetic rats and in thermally
hypoalgesic diabetic rats
In this study we have isolated a particular type of small-
sized caps−lpH+ DRG neurons. These neurons belong to
a population of very small DRG neurons based on size/
capacitance classification used by Petrusca et al. [21].
Small size and specific action potential parameters of
these neurons, including long AP width, high AP over-
shoot and slow AHP recovery, allow us to classify them
as C-fiber nociceptors [25]. Additionally, these neurons
have specific traits of NGF-dependent peptidergic nocicep-
tors such as IB4-negative capsaicin-insensitive phenotype,
expression of TTX-resistant high-threshold sodium (Nav1.8)
and ASIC channels and absence of low-threshold sodium
channels (Nav1.9) [26, 27, 40–42]. Thus, the caps
−lpH+ neu-
rons can be classified as NGF-dependent peptidergic ASIC-
expressing C-fiber nociceptors.
Our results demonstrate that upregulation of T-type
current under diabetes is not accompanied by significant
changes in its steady-state or kinetic parameters. It implies
an increase in either density of functionally active chan-
nels or their single channel conductance without changes
in their gating properties. Classifying the caps−lpH+ neu-
rons helps to better understand possible pathways of T-
type current upregulation in these neurons that leads to
their increased excitability in diabetes. Assumed NGF de-
pendence of the caps−lpH+ DRG neurons implies possible
involvement of NGF-dependent signal transduction
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remodeling as they were found to be involved in gener-
ation of inflammatory pain [43–45] and are activated at a
painful stage of diabetes [46]. The other reason for T-type
channel upregulation may be related to acidosis and activa-
tion of ASIC-dependent signal transduction pathways at an
advanced stage of diabetes [14, 47]. Thus, the caps−lpH+
neurons can potentially be involved in nociception by
means of T-type current upregulation mediated by ASIC-
and NGF-dependent pathways. Additionally, accessory
HVA Ca2+ channel subunit α2δ was found to increase T-
type current density [48], so elevated expression of the
Cav3.2 channels could be induced by upregulation of
the α2δ subunit expression found in STZ-induced
diabetes [49].
Differential modulation of T-type channels in caps+
[10] and caps−lpH+ (this study) neurons in the same
thermally hypoalgesic diabetic rats implies that T-type
current expression in diabetes depends on neuronal sen-
sory modality rather than on pathogenic conditions
(hyperglycemia, ischemia, etc.) common for all types of
DRG neurons. That is, diabetes-induced modulation of
T-type channels may depend upon TRPV1 and ASIC
sensory pathways in caps+ and caps−lpH+ neurons,
respectively.
Previous studies have shown that thermal hyperalge-
sia/hypoalgesia in diabetic animals correlates with T-
type channels upregulation/downregulation in caps+
DRG neurons [10]. Multiple behavior tests during STZ-
induced diabetes development has proven that thermal
hyperalgesia developing at an early stage of diabetes
(2–4 weeks) [4, 5] converts to hypoalgesia by 8–12
weeks of diabetes [6, 7] (for review see [8]) while other
pain symptoms (spontaneous pain, mechanical hyper-
algesia, and tactile allodynia) persist through this later
stage of diabetes development [7, 8, 12]. Upregulation
of T-type current found in the caps−lpH+ neurons of
long-term diabetic (9–13 weeks) and thermally hypoal-
gesic diabetic rats strongly suggests their involvement
in nonthermal nociception persisting at a later stage of
diabetes.
Upregulation of Cav3.2 T-type channels leads to increased
excitability of the caps−lpH+ DRG neurons and may cause
pain in longer-term diabetes
Previously it has been found, that Cav3.2 isoform of T-
type channels is the major contributor to T-type current,
which is upregulated in small- and medium-sized DRG
neurons of diabetic rats. It has been shown that this up-
regulation is necessary for development of hyperalgesia
[4, 5]. In this work, almost complete inhibition of T-type
current by 50 μM of Ni2+ (Fig 4d) suggests that the
Cav3.2 isoform (IC50 = 13 μM [29]) makes a major con-
tribution to T-type current in the caps−lpH+ neuronssince other two T-type channel α1 subunit isoforms,
Cav3.1 and Cav3.3, are less susceptible to inhibition by
Ni2+ (IC50 = 250 μM and 216 μM, correspondently [29]).
Efficient conversion of ADP to AHP and decrease of AP
threshold in the caps−lpH+ neurons of diabetic rats
under 50 μM of Ni2+ (Fig 4e) and selective Cav3.2
blocker, amiloride [30–32] also proves that Cav3.2 chan-
nels determine excitability of the neurons under STZ-
induced diabetes.
The major modulatory role of T-type channels in AP
generation threshold compared to TTX-R and TTX-S
sodium channels in the caps−lpH+ neurons is deter-
mined by a substantially higher value of T-type current
at depolarization steps equal or lower than the AP
threshold level. For example, the T-type current density
is about 4 times higher than the density of sodium
current at membrane depolarization to potentials close
to AP generation threshold for the caps−lpH+ neurons
(see Results, Fig 2b and Fig 8a, b). It is in contrast to
other types of DRG neurons where T-type currents are
small and sodium channels play a major modulatory role
in defining an AP threshold. For example, TTX-R so-
dium channels determine an AP threshold in Type 2
DRG neurons [50].
Upregulation of T-type Ca2+ current in the caps−lpH+
neurons of diabetic rats shown in this study could poten-
tially modulate peripheral nociceptive input to the dorsal
horn at the level of peripheral and central terminals of these
neurons. It has been shown that pain stimuli are detected
by transducer channels (TRP class thermal/chemical recep-
tors, ASICs, P2X3, etc.) and converted to subthreshold
depolarization [51]. This depolarization reaches an AP
threshold by means of generator potentials, the main role
in which in nociceptive DRG neurons is supposed to be
played by some voltage-gated sodium channels [51].
They are expressed in nerve endings of C-fibers in vivo
[52] and are present in vitro in distal axons of small
DRG neurons at densities allowing amplification of a
subthreshold depolarization [53]. In this study we have
found that somatic subthreshold depolarization may reach
the AP threshold in the caps−lpH+ neurons due to T-type
calcium rather than sodium channels (Fig 4e, g, i).
Moreover, T-type channel upregulation in longer-term
diabetes would naturally cause peripheral sensitization
of the caps−lpH+ DRG neurons by producing AP bursts
instead of single APs (Fig 6d). Here we have demon-
strated that diabetes-induced upregulation of T-type
channels in the caps−lpH+ neurons leads to an increase
in percentage of neurons demonstrating double-spike
bursts from 0 % in control to 25 % in longer-term
diabetes. This may certainly contribute to painful sen-
sations experienced by diabetic patients since AP bursts
are most effective in producing dorsal horn neuronal
plasticity [54] and supporting chronic pain states [55, 56].
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form of T-type Ca2+ channels in peripheral axons of DRG
neurons have been recently reported [57] additionally con-
firming that these channels may amplify generator poten-
tials in peripheral endings of the caps−lpH+ DRG neurons.
Diabetes-induced changes in functional expression of
T-type channels in the caps−lpH+ neurons might also
contribute to pain processing at the level of central ter-
minals of these neurons. It has been shown that T-type
channels regulate the frequency rather than the ampli-
tude of miniature excitatory postsynaptic currents re-
corded in dorsal horn neurons from acute spinal cord
slices [58]. The effect was specific for superficial dorsal
horn neurons compared to deeper non-nociceptive lam-
ina [58]. These findings provide evidence for the role of
presynaptic T-type channels in synaptic transmission be-
tween nociceptive DRG and secondary dorsal horn neu-
rons. Thus, diabetes-induced T-type channel remodeling
observed in this work may modify synaptic transmission
between the cap−lpH+ and dorsal horn neurons at the
level of central terminals in this way contributing to an
increased level of pain in longer-term diabetes.
Conclusions
Caps−lpH+ DRG neurons exhibit increased excitability in
long-term diabetic and thermally hypoalgesic diabetic
rats and likely contribute to nonthermal nociception at
the later-stage diabetes. Their hyperexcitability is caused
by upregulation of T-type calcium channels mainly rep-
resented by Cav3.2 subtype. Thus, Cav3.2 channels of
caps−lpH+ nociceptive DRG neurons can be a thera-
peutic target for treating pain symptoms in later-stage
diabetic patients.
Methods
All animal care and handling was done in accordance
with protocols of the Animal Care and Use Committee
at Bogomoletz Institute of Physiology.
Induction of experimental diabetes
Diabetes was induced by injection of STZ in young
(3 weeks old to obtain animals with 6–7 weeks long dia-
betes) or adult (5–6 months old to obtain animals with
9–13 weeks long diabetes) male Wistar rats (50 mg/kg,
i.p.). STZ was prepared in 100 mM citric acid, pH 4.2,
on ice. Blood glucose level was measured on third day
with glucometer Glucotrend (Boehringer Mannheim,
Germany). If a blood glucose level was below 25 mM, an
additional STZ injection was given (25–40 mg/kg, i.p.)
that increased probability of hyperglycemia development
in those animals. The blood glucose level was measured
again on third day, during the course of disease develop-
ment and on a day of DRG isolation. All animals used in
our experiments had the blood glucose level higher than25 mM after establishment of hyperglycemia and before
DRG isolation. Animals in the control group were of the
same age as ones in the diabetic group and were injected
with a saline instead of STZ.
Assessment of thermal sensitivity
Nociceptive responses to thermal stimuli were measured
at room temperature using a paw thermal stimulation
system (Uga Basile, Italy) consisting of a plastic chamber
with a transparent glass floor and radiant heat source
positioned beneath the floor to deliver a thermal stimu-
lus to the plantar side of the hind paw. Paw withdrawal
latency (PWL) was assessed in seconds by the automatic
timer as a time interval between a start of a thermal
stimulus delivery and a paw withdrawal, when a photo-
cell detected interruption of a light beam reflection.
PWL was measured in control and diabetic rats a day
before the experiment. One-way ANOVA was used to
reject the null hypothesis that control and diabetic
groups have the same mean PWL. Diabetic rats were
considered hypoalgesic if their PWL was higher than the
right bound of the 95 % confidence interval for PWL
distribution obtained for the control animals (see [10]
for details). Similarly, the diabetic rats were considered
hyperalgesic if their PWL was lower than the left bound
of the 95 % confidence interval obtained for the control
rats.
Acutely dissociated DRG neurons
Lumbar L4-L6 DRG were isolated from diabetic or con-
trol animals of the same age. Ganglia were treated for
30 min at 36 ° C with 0.15 % of the type 4 collagenase,
250 U/mg (Worthington, USA) and 0.15 % trypsin, 204
U/mg (Worthington, USA) in the Tyrode’s solution con-
taining in mM 140 NaCl, 4 KCl, 2 MgCl2, 2 CaCl2, 10
glucose and 10 HEPES, adjusted to pH 7.4 with NaOH.
They were washed from enzymes in fresh Tyrode’s solu-
tion and mechanically dissociated by triturating them
through a series of Pasteur pipettes polished to several
narrowing diameters. Isolated cells were collected by
centrifugation, resuspended in fresh Tyrode’s solution and
kept at room temperature until use in electrophysiological
experiments during 3–8 h after isolation.
Electrophysiology
Whole-cell electrophysiological recordings were per-
formed at room temperature using RK-400 patch-clamp
amplifier (Intracel, UK) conventional techniques. Voltage
and current commands and digitization of membrane
voltages and currents were controlled using an ITC-16
interfaced with TIDA data acquisition software (HEKA,
Germany) running on a PC computer. Data analysis was
accomplished using MATLAB 7.5 (MathWorks, USA)
and Origin 8.0 (Microcal Software, USA). Currents were
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capacitance (Cm) values were taken directly from dials of
the amplifier after electronic subtraction of capacitive
transients. Series resistance was compensated to the max-
imal extent possible (80-90 %). Linear leak subtraction
was used for all voltage-clamp recordings.
Patch pipettes were pulled from borosilicate glass
microcapillary tubes (Sutter Instrument, USA) using P-
97 Flaming/Brown micropipette puller (Sutter Instru-
ment, USA). They had resistance 2 to 3 MΩ when filled
with internal solutions. Two internal solutions were used
in the experiments. Solution 1 was used for typing neu-
rons, recording Ba2+ currents and in all current-clamp
experiments. It contained the following (in mM): 120
KCl, 4 MgATP, 30 HEPES, 2.25 CaCl2, 10 EGTA, 10
NaCl, pH 7.4 with KOH, 296 mOsm. Solution 2 was
used to record Na+ currents and contained the following
(in mM): 120 CsCl, 20 HEPES, 10 EGTA, 5 Mg-ATP, 0.4
Na-GTP, pH 7.2 with CsOH. DRG neurons were
clamped in a whole-cell configuration and typed in
Tyrode’s solution described above. All current-clamp ex-
periments were done after typing using the same exter-
nal solution with an addition of T-type channel blockers,
if necessary. To record Ba2+ currents the Tyrode’s solu-
tion in a bath was changed for the following (in mM):
165 tetraethylammonium (TEA)-Cl, 10 HEPES, 2 BaCl2,
pH 7.4 with TEA-OH, 305–315 mOsm. In order to iso-
late tetrodotoxin-sensitive (TTX-S) and resistant (TTX-
R) components of Na+ currents recordings were done
sequentially in (i) Tyrode’s solution, (ii) Tyrode’s solution
plus 1 μM TTX, and (iii) finally in a solution containing
(in mM): 150 choline chloride, 10 HEPES, 2 CaCl2, 2
MgCl2, 4 KCl, pH 7.4 with Tris-base. TTX-S current
traces were obtained by subtracting recordings per-
formed in the second solution from the ones performed
in the first. TTX-R current traces were obtained by sub-
tracting recordings performed in the third solution from
the ones performed in the second. To compare sodium
currents in neurons of diabetic and normal rats record-
ings were done in Tyrode’s solution with the addition of
La3+ (10 μM) to block calcium channels and TEA
(20 mM) to block potassium channels. The internal so-
lution 1 (KCl-based) had a predicted junctional poten-
tial of about −5 mV against the Tyrode’s solution and
about −9 mV against the TEA-based external solution.
The internal solution 2 (CsCl-based) had a predicted
junctional potential of about −8 mV against the Tyrode’s
solution. Clempex 8.2 software was used to calculate pre-
dicted junctional potentials. Reported membrane poten-
tials were not corrected for these values.
Neurons were typed using voltage-step stimulation
protocols 1 and 2 taken from [21]. Protocol 2 was used
as a routine to differentiate types of neurons. It included
depolarization steps from a holding potential of −100 mV(3.5 s) to test potentials from −60 to +40 mV (200 ms)
with 20 mV increments. Protocol 1 was used to examine
hyperpolarization activated currents included hyperpolari-
zation steps from a holding potential of −60 mV (4 s) to
test potentials from −60 to −110 mV (500 ms) with
10 mV increments. Protocol for activation of Ba2+ cur-
rents included depolarization steps from a holding poten-
tial of −100 mV (3.5 s) to test potentials from −80 to
0 mV (250 ms) with 10 mV increments. Protocol for acti-
vation of sodium currents was similar to the later one, but
test potentials ranged from −80 to +15 mV with 5 mV in-
crements. The steady-state inactivation protocol for Ba2+
currents included depolarization steps to a test potential
of −40 mV (250 ms) from a holding potential ranging
from −100 to −40 mV (3.5 s) with 10 mV increments. The
steady-state inactivation protocol for Na+ currents in-
cluded depolarization steps to a test potential of −10 mV
from a holding potential ranging from −100 to −10 mV
(3.5 s) with 10 mV increments.
The reverse potential for a transient component of Ba2+
current, mainly mediated by the Ni2+-sensitive Cav3.2
channels, was obtained using KCl-based internal solution
and Ba2+-,TEA-Cl-based external solution by extrapola-
tion of Ni2+-sensitive current–voltage curve to a zero
current value. Ni2+-sensitive current was obtained by sub-
traction of recordings performed in external solutions
with and without Ni2+ (50 μM).
The protocol for action potentials (APs) generation
consisted of a series of increasing current injections
(350 ms) evoking incremental depolarization (2–3 mV
per each step) from a holding potential of −90 mV.
Analysis
Two parameters of AP were used in order to compare
excitability of DRG neurons in normal and diabetic con-
ditions. The first parameter, the AP threshold, was de-
fined as a potential at an inflection point in a trace part
preceding an AP upstroke at a threshold current stimu-
lation. This part of a trace was fitted by the sum of two
exponentials: one - to fit a time course of subthreshold
membrane depolarization [59] and another - to fit a part
of a trace in the interval between an AP threshold and
an AP upstroke [60, 61]. An inflection point was deter-
mined as the one, at which a second derivative of a fit-
ting function turned zero. A second AP parameter
determining neuronal excitability used in this study was
an area under the afterdepolarization potential (ADP) or
above the afterhyperpolarization potential (AHP) deter-
mined at a threshold depolarization invoking an AP. The
ADP/AHP area was measured in mV*ms.
Total Ba2+ current was separated into transient and
persistent components (Fig3a). A transient component
was calculated as a difference between total current and
mean current at the end of a voltage step. The current
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ent component. Voltage-activated conductance of transi-
ent current, G(V), was calculated as peak density of
transient current divided by a driving force V – Vr,
where V is a membrane potential and Vr is a reversal po-
tential of transient current. Vr was found by extrapola-
tion of the current–voltage curve to a zero current
value, as described above in section Electrophysiology, to
be equal +30 mV. G(V) and steady-state inactivation
I(V) were described with single Boltzmann distributions
of the following forms:
G Vð Þ ¼ Gmax= 1 þ exp − V−V 50ð Þ=kÞðð ð1Þ
and
I Vð Þ ¼ Imax= 1 þ exp V−V 50ð Þ=kð Þð ð2Þ
In these equations Gmax and Imax are maximal conduct-
ance and steady-state inactivation current density, corre-
spondently; V50 is a membrane potential at which a half of
the Gmax or Imax values are reached and k is a slope factor.
In a range of voltage steps from −80 to −40 mV both tran-
sient and persistent components of total Ba2+ current
were mediated mainly by the T-type channels (data not
shown). Beginning with a voltage step to −30 mV N-
and other types of high voltage-activated (HVA) cur-
rents were found to substantially contribute to the total
Ba2+ current (data not shown) so that a transient com-
ponent mediated by the T-type channels could not be
determined at this voltage step without blocking HVA
channels. We estimated a transient component value at
a voltage step to −30 mV from the best Boltzmann
function fit of a steady-state transient current activation
curve (G(V)/Gmax) in a range of −80 to −30 mV. Fit-
ting was done with a MATLAB fit function (Math-
Works, USA) using a nonlinear least-squares method
and the best fit was determined by the highest score of
the goodness of fit parameter adjrsquare. At the end of
fitting procedure the parameter adjrsquare was in a
range of 0.980 - 0.993.
Statistical comparisons were done using a paired Stu-
dent’s t-test when T-type current inhibitors were used
and unpaired Student’s t-test when comparing data ob-
tained from diabetic and normal rats. One-Way ANOVA
was used to find out that measured values were not sig-
nificantly different between animals within control and
diabetic groups and could be combined into cumulative
control and diabetic samples to be compared with the
Student’s t-test. Intergroup differences with p < 0.05 were
considered to be significant. Factors that might influence
the difference between control and “diabetic” neurons
such as sex, litter or age were excluded by the following de-
sign. Male siblings from several litters with approximately
the same age (the difference was within 1 week) wereseperated into control and “diabetic” groups that were
blindly taken care of side by side. Direct correlation be-
tween an ADP/AHP area or an AP threshold and T-type
current values was established using Pearson correlation
test that was done on data pooled together from diabetic
and control animals.
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